, FemTech III is Actively Investing!

Next Pitch Call

May 8th, 2024 | 9:30 AM PT

Every month, members will have the opportunity to join in on the pitch calls with other members and our lead partners. We always welcome your business questions and consumer expertise, but if you can’t attend, you’ll always be able to listen to the recording on your dashboard when it’s more convenient.

Missed the last pitch call? Catch up here!

Featured

Mar 13, 2024

The Metapause Pitch and Q&A

Mar 13, 2024

Mamaya Health Pitch and Q&A

Mar 13, 2024

Mamaya Health and The Metapause Evaluation & Discussion

Mar 13, 2024

View Past Pitches

The Fund

The Portfolia FemTech Fund focuses on emerging technologies, products and services improving women’s health and wellness throughout their lives.

The dashboard is where our innovative model of collaborative, transparent investing comes to life. Your dashboard will provide detailed company information (i.e., company updates, companies in diligence, new investments), recordings of company pitches, and links for upcoming events.

The Portfolia platform is designed to bring you as close to the investing process as you’d like to be -- and we hope you’ll join in regularly to lend your business and consumer expertise.

The Companies

Company Logo Gallery

Apollo Neuroscience

Apollo Neuro offers a wearable consumer wellness device intended to help manage stress, challenging life transitions, and to promote a healthy lifestyle.

Attn: Grace

Attn Grace is a sustainable wellness brand designed for women, creating more sustainable solutions for women to combat bladder leakage.

Inherent Biosciences

A molecular diagnostics company at the intersection of epigenetics and AI tackling clinical problems where epigenetics appears to be involved such as infertility.

Maude

Maude is setting new standards for sexual wellness and works closely with factories to create body-safe, accessible essentials for all.

Revisit their pitch calls

INCREASE CAPITAL COMMITMENT

Increase your capital in the fund!

Companies In Diligence

Featured

A developer of cancer diagnosis devices to detect ovarian cancer. The device can be used for conducting biopsy and treating uterine fibroids with various energy methods using a proprietary visualization system, enabling doctors to treat cancer-suffering patients effectively.

Operator of a women's healthcare technology company intended to aid in the diagnosis of active endometriosis.

If there are no companies in diligence currently, you can still volunteer and we'll contact you when a new one is being assembled

JOIN A DILIGENCE TEAM

Refer A Company

The FemTech III fund will invest in 8-12 companies, from Seed to pre-IPO. We consider companies with solutions in the market, and we invest in both female- and male-led teams with a preference for gender-balanced executive teams. We only invest in companies with a U.S.-based C-Corp. Please submit the company information below or email companies@portfolia.com with questions.

Refer a company

The Numbers

Fund Performance Updates

2023 FemTech III Fund Performance Updates

By accessing this report, you agree to hold all non-public information in the strictest confidence and not for distribution. The 2023 financial statements are as of and for December 31, 2023.

View Report

The Leadership Team

The Portfolia FemTech III Fund is led by a world-class team of highly sophisticated and experienced investors who are leaders in their respective fields, as venture capitalists, angel investors, and innovators. They bring an expert skill-set including sourcing, diligence, deal negotiation, executive recruitment, strategy and governance. Click on photos for full bios.

Featured